Medicine
Rivaroxaban 20 mg tablet
Rivaroxaban 20 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Key facts
- Active ingredient (INN)
- Rivaroxaban
- Brand
- Sold under the generic name
- Strength
- 20 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 blister pack, 30 tablets, 90 tablets and 10 more
- Manufacturers
- Alembic PharmaceuticalsIndiaIndoco RemediesIndiaChangzhou Pharmaceutical Factory
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AF01 Rivaroxaban
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 May 2025
- Identifiers
- RxCUI 1114198, 1232082, 1232086 +2DailyMed set ID 5524f30f-789d-4f5c-8f7c-d03a475b6d34, 9fee7136-c8fd-4bea-ab15-7a0e7292396d, e62f23c6-89f2-4179-95dc-5732401b3f93 +1NDC 46708-348, 14445-184, 62332-348 +1Application ANDA210301, ANDA218445, ANDA216995
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 46708-348-10 | Alembic PharmaceuticalsIndia | 21 May 2025 |
| 30 tablet, film coated in 1 bottle | 46708-348-30 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 90 tablet, film coated in 1 bottle | 46708-348-90 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 1000 tablet, film coated in 1 bottle | 46708-348-91 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 100 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 62332-348-10 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 30 tablet, film coated in 1 bottle | 62332-348-30 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 90 tablet, film coated in 1 bottle | 62332-348-90 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 1000 tablet, film coated in 1 bottle | 62332-348-91 | Alembic PharmaceuticalsIndia | 14 May 2025 |
| 1000 tablet, film coated in 1 bottle | 14445-184-00 | Indoco RemediesIndia | 11 August 2025 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 14445-184-10 | Indoco RemediesIndia | 11 August 2025 |
| 30 tablet, film coated in 1 bottle | 14445-184-30 | Indoco RemediesIndia | 11 August 2025 |
| 90 tablet, film coated in 1 bottle | 14445-184-90 | Indoco RemediesIndia | 11 August 2025 |
| 30 tablet, film coated in 1 bottle | 55488-0542-1 | Changzhou Pharmaceutical Factory | 1 February 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Rivaroxaban 20 mg tablet.
Other strengths and forms of Rivaroxaban
Clinical summary
Rivaroxaban is a factor Xa inhibitor. It is available as tablets, oral suspension and kits. MedsAcross supplies Rivaroxaban for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RivaroxabanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Xarelto prescribing information (Janssen Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Xarelto: European public assessment report (EPAR) · European Medicines Agency
- Rivaroxaban Accord: European public assessment report (EPAR) · European Medicines Agency
Need Rivaroxaban 20 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.